Efficacy and safety of romiplostim N01 in cancer treatment–induced thrombocytopenia: Results from a phase II off-label study in China
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Yu Zhang, Qijia Zheng, Nanxi Dong, Linlin Huang, Hangping Ge, Xianfu Sheng, Jingjing Xiang, Wenbin Liu, Dijiong Wu, Jianping Shen, Baodong Ye
Institution: Zhejiang Chinese Medical University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417018341
Cites:
Cited by:
Related to: